A nationwide study of multimedicine use in people treated with cardiovascular medicines in Australia.

Andrea L SchafferJoel ChiaJonathan Brett Sallie-Anne Pearson Michael O Falster

Published in: Pharmacotherapy (2022)

Multimedicine use is common in people treated with cardiovascular medicines and presents a risk for inappropriate prescribing. Understanding the comorbid conditions commonly treated concurrently with cardiovascular disease can help improve co-prescribing guidelines and develop a person-centered approach to multimorbidity treatment.

Keyphrases

cardiovascular disease
primary care
newly diagnosed
metabolic syndrome
adverse drug
clinical practice
cardiovascular risk factors
cardiovascular events